MMJ Biopharma Cultivation

MMJ Biopharma Cultivation is a leading US-based medical cannabis cultivation and research company located in Saint Petersburg, Florida.

We specialize in the development and production of innovative cannabinoid medicines, focusing on formulations combining CBD and THC to address serious medical conditions with limited treatment options.

Unlike companies operating within the broader cannabis industry, MMJ Biopharma Cultivation is pursuing FDA-approved pharmaceutical status, leveraging a unique research and development program and DEA regulatory manufacturing guidelines. Our commitment to scientific rigor and personalized dosing aims to provide a non-addictive alternative to opioid pain management.

Currently, we are preparing to cultivate a significant initial crop of 5,000 plants, marking a pivotal step in our mission to unlock the therapeutic potential of cannabis for patients in need.